Sarah P. Psutka, Assistant Professor of Urology at the University of Washington, shared on X:
“A massive thanks to the organizers of the UROonco24 meeting in stunning Budapest! Congrats on a phenomenal program! I’m so grateful to be part of this incredible international community of UroOncs.”
Shilpa Gupta retweeted this post, adding the following:
“Thanks Morgan Roupret, Arnulf Stenzl for such a fantastic UROonco24 meeting! Loved the short talks format & discussions around pertinent & controversial clinical topics! Declan Murphy, Gianluca Giannarini. Grateful for my amazing women in GU
friends!”
Source: Sarah P. Psutka/X and Shilpa Gupta/X
Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials. .